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Endometrial stromal sarcoma invading the
abdominal aorta treated with aortic replacement
Brandon C. Busuito, BS, Charles Adger West, MD, Nabila Rasool, MD, and
Craig Rogers, MD, Detroit, Mich
Endometrial stromal sarcomas are extremely rare tumors with few reports describing invasion of major blood vessels.
Tumors that primarily involve the abdominal aorta or invade the vessel secondarily are uncommon. Outcomes from
radical tumor resection and aortic reconstruction are thus poorly understood. We present a rare case of a symptomatic
recurrent endometrial stromal sarcoma with encasement of the infrarenal abdominal aorta requiring en bloc tumor
resection and in situ aortic replacement. (J Vasc Surg 2012;55:844-6.)
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entities and are rarely encountered by vascular surgeons.
Tumors may originate from the aortic wall as primary aortic
tumors and secondarily involve the vessel from adjacent
primary tumors or after local recurrence from prior tumor
resections. Most commonly, tumors that secondarily in-
vade the abdominal aorta are sarcomas.1 Clinical scenarios
that call for aortic resection and replacement are few;
therefore, indications are not clearly defined. We present a
rare case of a recurrent symptomatic uterine sarcoma; en-
dometrial stromal sarcoma (ESS) with encasement and
invasion of the infrarenal abdominal aorta requiring en bloc
tumor resection and in situ aortic replacement.
CASE REPORT
A 59-year-old woman was referred to our institution com-
plaining of progressively worsening abdominal pain and weight loss
over the previous year. She underwent a total abdominal hysterec-
tomy in 1980. In 1990, additional surgical treatment was required for
a recurrent tumor, which led to the discovery of an ESS involving the
ovary. At this time, a bilateral salpingo-oophorectomy was per-
formed. Six months later, the patient underwent an additional
tumor-debulking procedure for re-recurrence followed by che-
motherapy, including six cycles of doxorubicin, cisplatin, and
vincristine. On examination at presentation in 2010, a soft,
palpable mass was noted along the left midabdomen superior to
the umbilicus. On computed tomography (CT), an 8-cm  6-cm
tumor with a necrotic core was noted in the retroperitoneum with
evidence of encasement of the infrarenal aorta (Fig 1). Also,
pulmonary nodules as well as an enlarged left supraclavicular lymph
node were identified on CT of the chest. The lymph node and
abdominal mass at core needle biopsy were consistent with a
low-grade ESS, confirming metastatic stage IV disease. After mul-
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844idisciplinary review, complete tumor resection with possible vas-
ular reconstruction was recommended based on tumor biology
nd symptoms related to the mass.
From a midline incision and infracolic aortic exposure, proxi-
al and distal control of the aortoiliac segment was obtained from
he renal arteries to the common iliac bifurcation. The oncological
issection was carried out by removing the mass en bloc with
eripheral surrounding soft tissue, which included the anterior and
ateral peritoneal surfaces, the left kidney, and ureter. An attempt
as made to dissect the tumor off of the abdominal aorta; however,
he vessel-tumor interface was fibrotic and densely adherent, which
recluded peeling the tumor away from the aortic wall. These
onditions necessitated aortic replacement using a 12-mm polyes-
er tube, gel-impregnated vascular prosthesis (Gelsoft; Vascutek,
enfrewshire, Scotland, United Kingdom; Fig 2). There was no
emaining posterior peritoneal tissue for coverage available; there-
ore, the graft was encircled with an omental pedicle and oriented
n a retrocolic tunnel. An increased risk for graft infection was
erceived in this case given the visceral component of the resection
ureter) and the multisurgeon teams involved; thus, we chose to
oak the graft in rifampicin, 30 mg/mL, as a punitive measure.
istologic analysis of the tumor was consistent with a low-grade
etroperitoneal endometrial stromal sarcoma with evidence of vas-
ular infiltration (Fig 3, A and B). The patient experienced an
neventful hospital course, being dismissed on postoperative day
. She was started on adjuvant hormonal therapy (megestrol). At
months after the debulking procedure, the patient remains
ymptom-free, has no evidence of local or regional recurrence, or
dvancement of pulmonary disease by CT scan, and is continuing
ormonal therapy for systemic control.
ISCUSSION
An ESS is an uncommon tumor that accounts for1%
f all uterine cancers and 7% to 15% of uterine sarcomas
ffecting two per 1,000,000 women annually. The histopa-
hology of these tumors resembles stromal cells of the
roliferative endometrium and can be divided into low-
rade and high-grade tumors based on a threshold of 10
itotic figures per high-powered field.2,3
Most patients present at 40 to 55 years of age with
bnormal uterine bleeding, pelvic pain, and dysmenorrhea
ith up to 25% being asymptomatic.4 Diagnosis of early-
tage ESS tumors is challenging in this younger population
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lems.2,4 Currently, no imaging modality is reliably able to
diagnosis the condition.2 Ultrasound and magnetic reso-
nance imaging provide the more supportive details of the
pathology and are preferred. Histologic examinations fre-
quently miss the diagnosis of early-stage ESS with a failure
rate of up to 40%, which may explain a remote history of
hysterectomy for benign conditions in many patients that
present later with advanced disease.5
ESSs are slow-growing indolent tumors that have a
propensity to relapse in 36% to 56% of patients with early
disease.2 The pattern of spread is to the peritoneum and
lung, which underscores the importance of preoperative
imaging. Angioinvasion is a common feature of these tu-
mors, beginning with the infiltration of myometrial veins
with further extension through ovarian veins into the infe-
rior vena cava (IVC).2,5 Most cases of cardiovascular in-
volvement have presented with tumor thrombus of the IVC
and in some with intracavitary extension into the heart.6,7
Fig 2. Intraoperative photograph after en bloc aortic and tumor
resection showing tumor resection area and replaced segment of
the infra-abdominal aorta with a 12-mm prosthetic graft.
Fig 1. Computed tomography (CT) scan demonstrating encase-
ment of the aorta in 270 degrees by the tumor mass.Of 19 patients identified in the literature with ESS involv- wng major blood vessels, all affected the IVC with only one
ound to involve the abdominal aorta.5 In this patient, the
umor involved the IVC and extended into the right atrium
nd also involved the abdominal aorta. Both the IVC and
bdominal aorta were replaced and the tumor was extracted
neventfully from the right atrium. The resection was
eported as complete with negative tumor margins and the
atient was still alive at 4 years after surgery. Our report is
he second example of ESS invading the abdominal aorta as
result of a local-region recurrence.
Surgical therapy with total abdominal hysterectomy
nd bilateral salpingo-oophorectomy is the mainstay surgi-
al treatment, yielding an 80% to 100% survival at 5 years,
nd offers the most important component of treatment;
owever, tumor recurrencemay occur after a latency period
f 10 to 20 years in 50% of patients.2,4,5,8,9 For locally
dvanced disease and advanced spread of ESS, cytoreduc-
ive surgery in the form of radical visceral resections and
ven isolated lung metastasectomy has been performed
ig 3. Photomicrographs demonstrate histology with hematoxylin-
osin staining of the para-aortic mass of endometrial stromal
arcoma tumor mass noted by asterisks (**) and the tumor-aortic
all interface (A); (arrow) denotes the aortic lumen (original
agnification,  40). An endometrial stromal sarcoma cell is
llustrated (arrowhead) infiltrating into the outer adventia with
urrounding inflammation and hemorrhage (B) (original magnifi-
ation,  100).ith acceptable survival from published reports.2,5,9 Pul-
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isolated lung metastasis and done so with curative intent in
those with soft-tissue sarcomas.9 More radical surgical ap-
proaches for ESS have produced acceptable results from avail-
able case reports and reviews of the literature and should be
considered if substantial residual tumor removal can be
achieved.5,9 Some evidence suggests that adjuvant chemo-
therapy may reduce local recurrence with the use of anthracy-
clines and ifosfamide; however, tumor responsiveness is vari-
able with no proven survival benefit.2,9 Adjuvant hormonal
therapy seems advantageous with most ESS tumors being
steroid receptor-positive. The use of progestins, aromatase
inhibitors, and gonadotropin-releasing hormone analogues
have shown favorable results in several studies andmay reduce
recurrence after radical tumor resection or early-stage surgical
treatment.9 Still, clear treatment recommendations remain
vague due to the rarity of this condition.
Secondary invasion of the aorta from other sarcomas is
extremely rare. In 2006, Schwarzbach et al10 reported a
single-institution experience evaluating results of retroperito-
neal sarcomas involvingmajor blood vessels. Out of 141 cases
in the series, 17.7% underwent vascular reconstruction for
vascular involvement. The IVC was affected by primary leio-
myosarcomas in the majority of these; however, isolated or
combined involvement of the abdominal aorta with other
adjacent large vessels was also reported.10 Complete resect-
ability was achieved in most patients and survival was best
predicted by a negative margin resection in the study. Simi-
larly, in patients with low-grade ESS tumors, achieving a
tumor-free resectionmargin is themost important prognostic
factor affecting survival.2,4,5,8,9 In cases of advanced disease
where complete resectability cannot be guaranteed, major Sascular reconstruction in combination with tumor resections
ay be well justified in selected patients with slow-growing
SS tumors.
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